MacDougall Biomedical Communications  
   
 

Building Visibility & Valuation for the Life Sciences Industry

MacDougall Biomedical Communications brings a fresh, strategic approach to building visibility and valuation for its clients within the biotechnology, medical device, and life science industries.

 
     
 

Amplify Your Success Around the Globe

MBI's media team has the skills and relationships with national and international print, online and broadcast media to get your story told.

 
     
 

Build Credibility and Liquidity on Wall St.

MBI has a seasoned investor relations team and a proven track record of building or restoring credibility with investors and analysts.

 
     
 

Branding and Positioning are the Keys to Long-term Success

MacDougall Biomedical Communications specializes in branding and rebranding private and public life science companies. A clear and consistent corporate message is the keystone to a successful communications plan.

 
     
 

Get Your Message to the Right Audience at the Right Time

MBI monitors and evaluates important industry events to proactively secure opportunities for its clients.

 
     
 

Building Visibility & Valuation for the Life Sciences Industry

MacDougall Biomedical Communications brings a fresh, strategic approach to building visibility and valuation for its clients within the biotechnology, medical device, and life science industries.

 
     
 

Amplify Your Success Around the Globe

MBI's media team has the skills and relationships with national and international print, online and broadcast media to get your story told.

 
     
 

Build Credibility and Liquidity on Wall St.

MBI has a seasoned investor relations team and a proven track record of building or restoring credibility with investors and analysts.

 
     
 

Branding and Positioning are the Keys to Long-term Success

MacDougall Biomedical Communications specializes in branding and rebranding private and public life science companies. A clear and consistent corporate message is the keystone to a successful communications plan.

 
     
 

Get Your Message to the Right Audience at the Right Time

MBI monitors and evaluates important industry events to proactively secure opportunities for its clients.

 
     
   

MBI is a leading strategic communications firm focused on scientific, medical and corporate communications. MacDougall Biomedical Communications' sole focus is to fulfill the unique communications needs of companies and organizations that are developing products or services within the life sciences industry. Our client profiles include:
  • Private and public biotechnology companies
  • Global and specialty pharmaceutical companies
  • Medical device and diagnostic companies
  • Universities and research institutions
  • National and international biotechnology industry organizations
  • International economic development organizations
  • Organizations providing support services/products for the life sciences industry

The team at MBI prides itself on being innovative and creative with a direct, honest and results-oriented approach.

 

Download 2009 Life Science Industry Conference Calendar


Upcoming Events

BioCentury/Thomson Reuters: Newsmakers in the Biotech Industry
New York, NY
September 10, 2009

BIO Investor Forum
San Francisco, CA
October 28-29, 2009

BIO-Europe 2009
Vienna, Austria
November 2-4, 2009
more >


Industry Resources


more >

 
           
Achillion Pharmaceutics (ACHN) Altus Pharmaceuticals (ALTU) Array BioPharma (ARRY) CellDex (CLDX) Clinical Data (CLDA) CombinatoRx (CRXX) Dyax Corporation (DYAX) Idera Pharmaceuticals (IDRA) Microfluidics Corporations (MFLU) Molecular Insight (MIPI) Myriad Pharmaceuticals (MYRX) NovaDel Pharma Inc. (NVD) Repligen Corporation (RGEN) SeraCare Life Sciences (SRLS) Synta Pharmaceuticals (SNTA) Targacept (TRGT) ZymoGenetics, Inc. (ZGEN) Advanced Molecular Design Advanced Molecular Design Arcion Therapeutics Argos Therapeutics Artisan Pharmaceuticals Ascent Pharmaceuticals BaroFold BioAssets Development Corp Boston Biocom CaliberTherapeutics Cambria  Biosciences CardioKine CircuLite, Inc. Conatus Pharmaceuticals CORTRIA Corporation Dimerix Enanta Pharmaceuticals Epitome Biosystems FORMA Therapeutics Fate Therapeutics Gloucester Pharmaceuticals HistoRx Inotek Pharmaceuticals Kem Pharmaceuticals Mersana Nativis NeurAxon Neurotech USA Nomir Medical OcuCure Therapeutics PICO Pharmaceuticals Plextix BioSystems Proteostasis Therapeutics ROXRO Pharmaceuticals SCYNEXIS, Inc. Seaside Therapeutics SmartCells, Inc. SRU Biosystems Surface Logix Symphogen Synageva BioPharma Taligen Therapeutics Topigen Pharmaceuticals Transmolecular VirDante Pharmaceuticals Zelos Therapeutics AstraZeneca Biotechnology Industry Organization Excel Medical Ventures Galderma Halloran Harvard Clinical Research Institute HealthCap PureTech Ventures Red Sky Partners SwedenBio